Ask AI

Advancing Patient-Centered Myelofibrosis Care: Strategic Approaches to JAK Inhibitor Selection, Sequencing, and Supportive Management

Optimize care for patients with myelofibrosis by enhancing your understanding of the latest testing guidelines, approved therapies, and management strategies through an interactive decision support tool, text modules, downloadable slides, a ClinicalThought commentary, expert think tank, and interactive patient toolkit.

Share

Program Content

Activities

Myelofibrosis Toolkit
Navigating Myelofibrosis: A Patient Toolkit 
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: June 12, 2026

Activities

AE Management in MF
Adverse Management and Supportive Care in Myelofibrosis Treatment
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: August 18, 2026

Expires: February 17, 2027

Myelofibrosis Biology to Treatment
Myelofibrosis: From Disease Biology and Risk Stratification to JAK Inhibitor Selection, Symptom Control, and Individualized Patient Care
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: August 25, 2026

Expires: February 24, 2027

Activities

AE Management in MF
Adverse Management and Supportive Care in Myelofibrosis Treatment
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: August 18, 2026

Myelofibrosis Biology to Treatment
Myelofibrosis: From Disease Biology and Risk Stratification to JAK Inhibitor Selection, Symptom Control, and Individualized Patient Care
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: August 25, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education In partnership with Smart Patients, Inc.

Supporters

This educational activity is supported by independent medical education grants from GSK, Incyte Corporation, and Sobi.

GSK

Incyte Corporation

Sobi

Partners

Smart Patients, Inc.

ProCE Banner